Sarepta Therapeutics Statistics

Total Valuation

BMV:SRPT has a market cap or net worth of MXN 42.44 billion. The enterprise value is 49.89 billion.

Market Cap	42.44B
Enterprise Value	49.89B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	104.79M
Shares Outstanding	n/a
Shares Change (YoY)	-2.62%
Shares Change (QoQ)	-5.99%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	85.35%
Float	99.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	10.99
PS Ratio	0.96
PB Ratio	1.75
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.22, with an EV/FCF ratio of -7.14.

EV / Earnings	-10.02
EV / Sales	1.14
EV / EBITDA	29.22
EV / EBIT	n/a
EV / FCF	-7.14

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.95.

Current Ratio	2.95
Quick Ratio	1.51
Debt / Equity	0.95
Debt / EBITDA	13.43
Debt / FCF	-3.31
Interest Coverage	-3.95

Financial Efficiency

Return on equity (ROE) is -21.37% and return on invested capital (ROIC) is -2.06%.

Return on Equity (ROE)	-21.37%
Return on Assets (ROA)	-1.52%
Return on Invested Capital (ROIC)	-2.06%
Return on Capital Employed (ROCE)	-3.34%
Revenue Per Employee	32.27M
Profits Per Employee	-3.63M
Employee Count	1,372
Asset Turnover	0.68
Inventory Turnover	2.40

Taxes

In the past 12 months, BMV:SRPT has paid 354.52 million in taxes.

Income Tax	354.52M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	372.29
200-Day Moving Average	n/a
Relative Strength Index (RSI)	52.34
Average Volume (20 Days)	3,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.23

Income Statement

In the last 12 months, BMV:SRPT had revenue of MXN 44.27 billion and -4.98 billion in losses. Loss per share was -50.83.

Revenue	44.27B
Gross Profit	8.14B
Operating Income	-1.58B
Pretax Income	-4.63B
Net Income	-4.98B
EBITDA	-665.53M
EBIT	-1.58B
Loss Per Share	-50.83

Full Income Statement

Balance Sheet

The company has 15.61 billion in cash and 23.12 billion in debt, giving a net cash position of -7.51 billion.

Cash & Cash Equivalents	15.61B
Total Debt	23.12B
Net Cash	-7.51B
Net Cash Per Share	n/a
Equity (Book Value)	24.21B
Book Value Per Share	231.12
Working Capital	33.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.49 billion and capital expenditures -2.50 billion, giving a free cash flow of -6.99 billion.

Operating Cash Flow	-4.49B
Capital Expenditures	-2.50B
Free Cash Flow	-6.99B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 18.39%, with operating and profit margins of -3.56% and -11.25%.

Gross Margin	18.39%
Operating Margin	-3.56%
Pretax Margin	-10.45%
Profit Margin	-11.25%
EBITDA Margin	-1.50%
EBIT Margin	-3.56%
FCF Margin	n/a

Dividends & Yields

BMV:SRPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.62%
Shareholder Yield	2.62%
Earnings Yield	-11.73%
FCF Yield	-16.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:SRPT has an Altman Z-Score of 1.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	3